"Our support of EUROSPINE reflects our belief in partnering with the most influential societies, study groups and congresses around the globe to advance better spine care and change the lives of more patients," said Chris Barry, chief executive officer at NuVasive. "Through our industry-leading set of procedural solutions, enabled by the technologies within Pulse, we continue to build the future of spine care to deliver more intelligent surgery."
NuVasive will host a lunch workshop, Pulse®: Where accuracy meets innovation, on Wednesday, October 19 from 11:45 to 13:45 CEST in Room Brown 2 of
NuVasive stand #98 will feature several Meet the Expert sessions:
- Pulse: An expert's review of its modalities—Join Dr.
Sven Vetteron Wednesday, October 19, as he presents Pulse, an enabling technology platform that integrates intraoperative neuromonitoring, global alignment, rod bending, radiation reduction and imaging enhancement, and navigation.
- Reline® 3D: An expert's guide to 3D deformity correction—Join Mr.
Stewart Tucker, Great Ormond Street Hospital, on Thursday, October 20, as he presents Reline 3D, a posterior fixation system optimized to address three-dimensional deformity present in the spine.
- X360™: An expert's journey with single-position surgery (SPS)—Join Prof.
Dr. Dominique A. Rothenfluh, Lausanne University Hospital, on Friday, October 21, as he presents X360, a comprehensive lateral approach to SPS that leverages advanced techniques and technologies to help surgeons deliver patient-specific surgical plans while enhancing OR workflow and efficiency.
For more information, please visit the NuVasive EUROSPINE webpage here.
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-sponsor-and-participate-at-eurospine-2022-301649953.html
Investor contact: Juliet C. Cunningham, NuVasive, Inc., 858-210-2129, email@example.com; Media contact: Melanie Ordoñez, NuVasive, Inc., 858-722-3899, firstname.lastname@example.org